Constipation Treatment Market is predicted to procure USD 10.1 Bn by 2032, Grow at a CAGR of 5.6%
According to the report, the global constipation treatment market was valued for $5.9 billion in 2022 and is estimated to reach $10.1 billion by 2032, exhibiting a CAGR of 5.6% from 2023 to 2032.
The study analyzes the important strategies, drivers, competition, market dynamics, size, and important investment regions.
Key Takeaways:
The laxative segment to maintain its leadership status throughout the forecast period.
The chronic idiopathic constipation segment to maintain its leadership status throughout the forecast period.
The prescribed drugs segment to maintain its leadership status throughout the forecast period.
North America to maintain its dominance by 2032.
Request Sample Copy of the Report:
https://www.alliedmarketresearch.com/request-sample/8560
Major Factors Driving the Growth of Constipation Treatment Market:
- Increasing prevalence of constipation: Constipation is a common problem that affects millions of people worldwide. The prevalence of constipation is increasing due to a number of factors, including aging, sedentary lifestyles, and poor diet.
- Rising demand for over-the-counter (OTC) constipation treatments: OTC constipation treatments are becoming increasingly popular due to their convenience and affordability. OTC constipation treatments include laxatives, stool softeners, and fiber supplements.
- Growing awareness of prescription constipation treatments: Prescription constipation treatments are becoming more widely known and accepted, as they can be more effective than OTC treatments for chronic or severe constipation. Prescription constipation treatments include prucalopride, linaclotide, and lubiprostone.
- Increasing investment in research and development: Pharmaceutical companies are investing heavily in the research and development of new and more effective constipation treatments. This is leading to the development of new drugs and devices that can help to improve the symptoms and quality of life for people with constipation.
Drivers:
- Rise in prevalence of Chronic disease such as chronic pain and cancer
- High presence of constipation drug manufacturers
- Increase in number of geriatric populations
Opportunities:
Rise in adoption of number of strategies by market players of constipation treatment drugs
Restraints:
Alternative options available for constipation treatment
Market Segmentation:
Product type:
- Laxatives: Laxatives are the most common type of constipation treatment. They work by increasing the amount of water in the stool or by stimulating the muscles of the colon to contract. Laxatives can be further segmented into:
- Bulk-forming laxatives
- Stimulant laxatives
- Osmotic laxatives
- Lubricant laxatives
- Stool softeners: Stool softeners work by increasing the water content of the stool and making it easier to pass.
- Fiber supplements: Fiber supplements work by adding bulk to the stool and helping it to move through the digestive system more easily.
- Other constipation treatments: Other constipation treatments include prescription medications, biofeedback therapy, and surgery.
Application:
- Chronic idiopathic constipation (CIC): CIC is the most common type of constipation. It is characterized by infrequent bowel movements and hard stools.
- Irritable bowel syndrome with constipation (IBS-C): IBS-C is a type of irritable bowel syndrome that is characterized by abdominal pain, cramping, bloating, and constipation.
- Opioid-induced constipation (OIC): OIC is a type of constipation that is caused by the use of opioid pain medications.
- Other applications: Constipation treatments are also used to treat other conditions such as hemorrhoids, anal fissures, and diverticular disease.
End user:
- Over-the-counter (OTC) constipation treatments: OTC constipation treatments are available without a prescription and can be purchased from pharmacies and grocery stores.
- Prescription constipation treatments: Prescription constipation treatments are available with a prescription from a doctor.
- Other end users: Other end users of constipation treatments include hospitals, clinics, and nursing homes.
Geography:
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, UK, Italy, Spain, Rest of Europe)
- Asia-Pacific (Japan, China, India, Australia, South Korea, Rest of Europe)
- LAMEA (Brazil, South Africa,, Saudi Arabia, Rest of LAMEA)
Request for Customization: https://www.alliedmarketresearch.com/request-for-customization/8560
Regional Growth Dynamics:
North America held the highest market share in terms of revenue in 2022, accounting for around two-fifths of the global constipation treatment market revenue. This is attributed to the high presence of constipation treatment drug manufacturers in North America and rising prevalence of chronic diseases such as cancer and chronic pain. However, the Asia-Pacific region is expected to witness the fastest CAGR of 6.4% from 2023 to 2032 and is likely to dominate the market during the forecast period, owing to rising number of geriatric populations, as geriatric population is more susceptible to chronic diseases such as constipation, chronic pain and others and increase in awareness among the people regarding constipation treatment.
Competitive Landscape
The key players in the global constipation treatment market are:
- Takeda Pharmaceutical Company Ltd.
- Abbvie Inc.
- Abbott Laboratories
- Sanofi S.A.
- Bausch Health Companies Inc.
- Bayer Ag
- Astrazeneca Plc
- Ironwood Pharmaceuticals, Inc.
- Prestige Consumer Healthcare Inc.
- Ardelyx Inc.
Recent developments:
In May 2023, Ironwood Pharmaceuticals, Inc., a GI-focused healthcare company, and VectivBio, a clinical-stage biopharmaceutical company, announced that they have entered into a definitive agreement for Ironwood to acquire VectivBio. This acquisition pioneered novel treatments for severe rare gastrointestinal diseases such as constipation.
Buy this Premium Research Report:
https://www.alliedmarketresearch.com/purchase-enquiry/8560
Key Questions Answered in the Intelligent Study
What is the market size and growth rate of the global and regional market by various segments?
What is the market size and growth rate of the market for selective countries?
Which region or sub-segment is expected to drive the market in the forecast period?
What Factors are estimated to drive and restrain the market growth?
What are the key technological and market trends shaping the market?
What are the key opportunities in the market?
What are the key companies operating in the market?
Which company accounted for the highest market share?
Why Choose Allied Market Research?
Industries’ Best Analysts
Exclusive Product Offerings
Customer Research Services
Dynamics Research Methodology
Comprehensive Reports
Latest Technological Advancements
Value Chain Analysis
Future Market Opportunities
Market Growth Dynamics
Quality Assurance
Post-sales Support
Continuous Report Update
Market Dynamics and Transformations
Economic Downturn Analysis: Impact of Recession in 2023
Pandemic’s Influence: Impact of Covid-19 Pandemic
Schedule a call with our analyst
Browse more latest healthcare reports:
Smoke Evacuation Systems Market https://www.alliedmarketresearch.com/smoke-evacuation-systems-market-A10370
Laser Therapy Devices Market: https://www.alliedmarketresearch.com/laser-therapy-devices-market-A10862
Nuclear Medicine Equipment Market: https://www.alliedmarketresearch.com/nuclear-medicine-equipment-market
About Allied Market Research:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
Contact:
David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Int’l: +1-503-894-6022
Toll Free: +1-800-792-5285
Fax: +1-800-792-5285
Editor Details
-
Company:
- The Wire Times
